These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 30759006)

  • 1. Improving Detection of Early Chronic Obstructive Pulmonary Disease.
    Labaki WW; Han MK
    Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S243-S248. PubMed ID: 30759006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity.
    Bhatt SP; Bodduluri S; Raghav V; Bhakta NR; Wilson CG; Kim YI; Eberlein M; Sciurba FC; Han MK; Dransfield MT; Nakhmani A
    Ann Am Thorac Soc; 2019 Aug; 16(8):982-989. PubMed ID: 30865842
    [No Abstract]   [Full Text] [Related]  

  • 5. A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease.
    Martinez FJ; Mannino D; Leidy NK; Malley KG; Bacci ED; Barr RG; Bowler RP; Han MK; Houfek JF; Make B; Meldrum CA; Rennard S; Thomashow B; Walsh J; Yawn BP;
    Am J Respir Crit Care Med; 2017 Mar; 195(6):748-756. PubMed ID: 27783539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
    Xie M; Wang W; Dou S; Cui L; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
    Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
    Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
    Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT.
    Jögi J; Ekberg M; Jonson B; Bozovic G; Bajc M
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1344-52. PubMed ID: 21365251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
    Karayama M; Inui N; Yasui H; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Nakamura Y; Watanabe H; Suda T
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1333-1342. PubMed ID: 31296985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction.
    Kitaguchi Y; Fujimoto K; Hanaoka M; Honda T; Hotta J; Hirayama J
    Int J Chron Obstruct Pulmon Dis; 2014; 9():805-11. PubMed ID: 25114520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
    Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
    Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts.
    Tho NV; Ryujin Y; Ogawa E; Trang le TH; Kanda R; Goto K; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Respirology; 2015 May; 20(4):594-601. PubMed ID: 25788016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort.
    Perez-Padilla R; Wehrmeister FC; de Oca MM; Lopez MV; Jardim JR; Muiño A; Valdivia G; Menezes AMB
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3549-3561. PubMed ID: 30464437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary physiology: future directions for lung function testing in COPD.
    Brusasco V; Barisione G; Crimi E
    Respirology; 2015 Feb; 20(2):209-18. PubMed ID: 25257934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methods other than spirometry in the early diagnosis of COPD.
    Şerifoğlu İ; Ulubay G
    Tuberk Toraks; 2019 Mar; 67(1):63-70. PubMed ID: 31130137
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.